Crossref
Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?
Journal of Cutaneous Oncology · 2023
DOI: 10.59449/joco.2023.01.09 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Oncology, 2023. Verfasst von Emily Kim und 7 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kim, E., Shalhout, S., Kaufman, H., Emerick, K., Patel, V., Garmen, K., Brownell, I., & Miller, D. (2023). Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?. Journal of Cutaneous Oncology. https://doi.org/10.59449/joco.2023.01.09
Vancouver
Kim E, Shalhout S, Kaufman H, Emerick K, Patel V, Garmen K, et al. Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?. Journal of Cutaneous Oncology. 2023. doi:10.59449/joco.2023.01.09
BibTeX
@article{Kim2023,
author = {Kim, Emily and Shalhout, Sophia and Kaufman, Howard and Emerick, Kevin and Patel, Vishal and Garmen, Khalid and Brownell, Isaac and Miller, David},
title = {Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?},
journal = {Journal of Cutaneous Oncology},
year = {2023},
doi = {10.59449/joco.2023.01.09}
}
EUVIMED